Search results
The AI effect: How a hot computing tool is tying ‘bio’ and ‘tech’ closer than ever - San Francisco...
The Business Journals· 5 hours agoJames Fraser had his doubts. After all, decades of scientific rigor say that discovering drugs —...
Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why
Zacks via Yahoo Finance· 11 hours agoShares of the commercial-stage biotechnology company, Krystal Biotech, Inc. KRYS, surged 36.5% year...
Jacobs Bottom Line Likely to Benefit From Red-Hot Weight-Loss Drug Market
Engineering News-Record· 6 hours agoAs Jacobs Solutions prepares for a big impending spin-off, it stands to benefit from three of the...
Zantac Not a Cause of Woman’s Cancer, Jury Says in First Trial Over Drug
US News & World Report· 9 hours agoCHICAGO (Reuters) -A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial ...
Crisis response provider pulls out of county after millions in public funds: How we got here
Dayton Daily News, Ohio via Yahoo News· 1 hour agoMay 23—RI International, a mental health and substance use crisis service provider, ended its crisis services on behalf of Montgomery County Alcohol, Drug Addiction and Mental ...
Zantac didn’t cause 89-year-old woman’s cancer, jury says in first trial over drug
NY Post via Yahoo News· 9 hours agoIllinois resident Angela Valadez had alleged that her cancer was a result of taking over-the-counter...
Oxford Nanopore Technologies Eyes TB Test as First In-House-Developed Diagnostic Test
GenomeWeb News· 7 hours agoDubbed Ampore-TB, the assay will enable TB drug resistance profiling directly from sputum samples in about six hours using the GridIon platform and an automated analysis pipeline ...
Drug tests can't tell difference between CBD and THC, putting consumers at risk
KTHV Little Rock· 24 hours agoWhile attitudes and laws around marijuana are changing, for people in specific jobs, using marijuana...
Weight-loss drugs help lift pharma's reputation
Axios· 13 hours agoThe poll also marks a rebound for pharma, which had seen its reputation decline after soaring to record heights amid the rapid development of COVID-19 vaccines. The big picture: Novo Nordisk ...
Guest opinion: Don't break the life-sciences industry - San Francisco Business Times
The Business Journals· 7 hours agoThe last discovery of a new class of antimicrobials that reached the market was in 1987. If...